?global_aria_skip_link_title?

Recherche

Translational Medicine and Biomedical Entrepreneurship

MAS

sitem-insel AG

Universität Bern UNIBE

Catégories
Lieu de formation

Berne 10 (BE)

Langue d'enseignement

anglais

Type de formation

Hautes écoles universitaires HEU - Formation continue: formations longues

Modalités temporelles

En emploi

Thèmes de formation

Électronique, microtechnique - Management, direction - Santé, soins, médecine

Domaines d'études

Gestion d'entreprise, économie d'entreprise - Médecine humaine - Sciences et technologie biomédicales - Technique médicale

Swissdoc

7.555.33.0 - 7.724.4.0 - 7.616.35.0

Mise à jour 25.11.2020

Description

Description de la formation

The program aims at educating academic specialists in the field of translational medicine and entrepreneurship. Participants are expected to acquire the necessary skills to initiate and implement the process of transition of biomedical products from the stage of development in industrial or basic science institutions into clinical applications with the ultimate goal of their commercialization. The focus will be on both, diagnostic and therapeutic (medtech, pharmaceutical) products.

The study program will be taught by “blended learning”, what allows distance e-learning. This will be supplemented by concept lectures, peer learning and interactive discussions with specialists.

The MAS allows to perform investigations at the edge between medtech or pharmaceutical industry and university based clinical development. Specialists in that area are desperately needed in both, industry and university.

Plan de la formation

The curriculum consists of prerequisites and six independent modules of various sizes. All modules comprise case studies, quizzes, article based learning and concept lectures. A blended e-learning program is the structural base of the curriculum.

Prerequisites
The prerequisites section is organized as e-learning and offers participants the possibility to refresh their knowledge according to their individual needs, covering the basics of biopharmacy, pharmaceutical technologies, medical technologies, OMICS technologies and biostatistics and epidemiology.

Module 1: Research and Development (4 ECTS)
Module 1 revises basic principles related to the discovery and development of medical devices and medicinal products.

Module 2: Good Manufacturing Practice and Quality Management (5 ECTS)
This module focusses on how to ensure that all activities linked with a translational process maintain the desired level of excellence required by regulatory agencies.

Module 3: Intellectual Property (3 ECTS)
Module 3 is dedicated to different types of Intellectual Property and legal aspects that are crucial for the successful commercialization of medical devices and medicinal products.

Module 4: Regulatory Affairs (5 ECTS)
The Module focuses on the approval process for bringing innovative products to the market and describes the role of regulatory agencies, public and government agencies and notified bodies along the translational pathway.

Module 5: Clinical Trial Design and Performance (6 ECTS)
Module 5 considers key characteristics of clinical trial design and conduct. Participants learn about the prerequisites for such scientific studies, the importance of understanding the pathophysiology of the underlying diseases, the definition of quantifiable endpoints by clinicians as well as data management and statistics.

Module 6: Biomedical Entrepreneurship and Management (13 ECTS)
Module 6 concentrates on aspects of entrepreneurship with special focus on medicinal products and medical devices including leadership in multidisciplinary teams, project management, business administration and financial aspects that are needed for the successful commercialization of medical devices and medicinal products.

Master thesis (24 ECTS)

Admission

Conditions d’admission

Participants should have

  • a MS or higher degree in life science, medicine, engineering science, natural sciences or equivalent and
  • at least 2 years of professional experience.

Participants can bring a proposal for an own translational medicine project on which they will work during their master thesis.

Zielpublikum

The program is open for all academic disciplines. For academics without a background in natural science, engineering or medicine, a special module «Prerequisites» has been developed.
It will allow those participants to acquire fundamental scientific-medical knowledge required for the program.

Coûts

CHF 31'500.-

Diplôme

  • Master of Advanced Studies MAS

Master of Advanced Studies in Translation and Entrepreneurship in Medicine, Universität Bern

Infos pratiques

Lieu / adresse

  • Berne 10 (BE)

Déroulement temporel

Début des cours

September 2020

Durée de la formation

2 years

Modalités temporelles

  • En emploi

Langue d’enseignement

  • anglais

Liens

Renseignements / contact

Prof. Dr. Juergen Burger, Director School, juergen.burger@med.unibe.ch
Dr. Pascale Anderle, deputy Director and program coordinator, pascale.anderle@sitem.unibe.ch
Jennifer Fischer, administration and communication, jennifer.fischer@sitem.unibe.ch

orientation.ch